Results 1 to 10 of about 1,652,787 (364)

Heterogeneous responses of dorsal root ganglion neurons in neuropathies induced by peripheral nerve trauma and the antiretroviral drug stavudine [PDF]

, 2014
© 2014 The Authors. European Journal of Pain published by John Wiley & Sons Ltd on behalf of European Pain Federation - EFIC®. Funding sources E.K.B. was funded by a BBSRC PhD studentship. A.N., A.S.C.R. and T.P. were funded by a Wellcome Trust Strategic
Boateng, E K, Huang, W, Novejarque, A, Pheby, T, Rice, A S C   +4 more
core   +1 more source

Proposed best practice for projects that involve modelling and simulation [PDF]

, 2017
Modelling and simulation has been used in many ways when developing new treatments. To be useful and credible, it is generally agreed that modelling and simulation should be undertaken according to some kind of best practice.
Anisimov, Burman, Burton, Cook, European Medicines Agency, Gaydos, Hemmings, Marshall, Smith   +8 more
core   +1 more source

Studies of medicines use by consumers

SHS Web of Conferences, 2012
One of the main aims of medicines’ use studies is to ensure rational use of them. Different types of medicines use studies exist – there are studies of medicines supply, consumption, behavior of medicines users and prescribers (advisers).
Salmane-Kulikovska I., Dobelniece S.
doaj   +1 more source

Medicines adherence: Involving patients in decisions about prescribed medicines and supporting adherence [PDF]

, 2009
It is thought that between a third and a half of all medicines1 There are many causes of non-adherence but they fall into two overlapping categories: intentional and unintentional.
Benson, J., Blair, J., Bowser, A., Calvert, N., Clyne, W., Crome, P., Haddad, P., Hemingway, S., Horne, R., Johnson, S., Kelly, S., Kuntze, S., National Collaborating Centre for Primary Care, Neilson, J., Nunes, V., O'Flynn, N., Packam, B., Patel, Mahendra, Smithson, H., Steel, J.   +19 more
core  

Pricing of drugs and donations: options for sustainable equity pricing. [PDF]

, 2001
Effective medicines exist to treat or alleviate many diseases which predominate in the developing world and cause high mortality and morbidity rates. Price should not be an obstacle preventing access to these medicines.
Ford, N, Herranz, E, Pérez-Casas, C
core   +2 more sources

Comprehensive scoping review of palliative care development in Africa: recent advances and persistent gaps

Frontiers in Health Services
Worldwide 56·8 million people need palliative care (PC), and Africa shows the highest demand. This study updates the 2017 review of African PC development, using a scoping review methodology based on Arksey and O'Malley's framework and the PRISMA-ScR ...
Fernanda Bastos, Fernanda Bastos, Eduardo Garralda, Eduardo Garralda, Alvaro Montero, Alvaro Montero, John Y. Rhee, John Y. Rhee, Natalia Arias-Casais, Emmanuel Luyirika, Eve Namisango, José Pereira, José Pereira, Carlos Centeno, Carlos Centeno, Carlos Centeno, Vilma A. Tripodoro, Vilma A. Tripodoro   +17 more
doaj   +1 more source

Race, Money and Medicines [PDF]

, 2006
Taking notice of race is both risky and inevitable, in medicine no less than in other endeavors. The literature on race as a classifying tool in clinical research poses this core dilemma: On the one hand, race can be a useful stand-in for unstudied ...
Bloche, Maxwell Gregg
core   +1 more source

Submission to the United Nations Secretary General's High Level Panel on Access to Medicines [PDF]

, 2016
Much of the current debate on health care goals, medical innovation and trade rules focuses on the misalignment between the need to provide incentives to innovation – mainly through a tight intellectual property (IPR) regime – and the resulting negative ...
Kale, Dinar, Mackintosh, Maureen, Orsenigo, Luigi, Simonetti, Roberto   +3 more
core  

International meeting: New diagnostic tests are urgently needed to treat patients with Chagas disease. [PDF]

, 2008
Trypanosoma cruzi infection is often not detected early on or actively diagnosed, partly because most infected individuals are either asymptomatic or oligosymptomatic.
Campaign for Access to Essential Medicines
core   +3 more sources

Pensando o processo saúde doença: a que responde o modelo biomédico? Considering the health-diesease process: what does the biomedical model answer to?

Saúde e Sociedade, 2002
Com o propósito de efetuar uma crítica ao modelo biomédico, mecanicista, hegemônico na doutrina e prática que informa a medicina na atualidade, o texto parte de uma síntese histórico-evolutiva que contempla a apresentaçao das idéias e personagens chave ...
José Augusto C. Barros
doaj   +1 more source